THE TAPE
CWK · Real Estate · $3.1B

Cushman & Wakefield Ltd.

$13.21▼ −0.68%
Last close
Relative strength
31RS
of 99, against every stock▲ +17 on the month
Turning up
Stock-specific strength
+6.8%
six months against Real Estate
52-week range
−24.1%
from the high
$10.88$17.40
Setup
On no screen
No base, flag or squeeze in place tonight. What is and is not there
No report date on the calendar.
Growth FLATProof SHOWN
Quarter to Sep 30, revenue +8% on a year ago
Why it is on no screen

CWK is off the screens on one check: relative strength.

A base has formed16.6 weeks, from 11.98 to 15.19.
Long enough to count16.6 weeks against 3 needed.
Shallow enough21.1% deep against 35% allowed.
Close to its pivot-13.0% from the pivot; listed down to -20%.
Relative strengthRS 31 against 70 needed.

Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.

Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
Support and resistance
Support below
$12.90
-2.3% · tested 9× · last 31 sessions ago
Resistance above
$13.67
+3.5% · tested 7× · last 6 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

Cushman & Wakefield Ltd. is not on any of the screens right now. Its relative strength rating is 31, and it sits in Real Estate.

Against its industry
Stock-specific strengthAhead of its industry over all three, in an industry that is behind the S&P 500 over six months: strength the group does not share.
One month against its industry
+12.4%
Three months against its industry
+2.8%
Six months against its industry
+6.8%

Read against an equal-weighted index of Real Estate, which is -2.3% against the S&P 500 over six months Not aligned.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 5.2% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$11.0B
+7.7% year on year
Operating margin
4.5%
Net margin
0.6%
Free cash flow
$200.2M
6.5% of market cap
Price to sales
0.28×
Price to earnings
44.4×

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Nov 4
Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$2.8B
+1.6% QoQ · +7.7% YoY
Gross margin
—
Net income
$52.1M
Positive
Free cash flow
$176.1M
Cash generating

What the numbers say

  • Revenue +7.7% year over year, +1.6% on the quarter
  • Good: Profitable: net income $52M, operating margin 4.6%
  • Good: Cash generating: operating cash flow $214M, free cash flow $176M
  • Net debt $2.12B · cash $489M
Revenue by quarter
Free cash flow
Net income
shares +0.6% in a year · net debt $2.1B
Final read
Growth: FLAT · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is whether the quarter repeats.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

None of the tracked funds held or sold it in their latest filings.

Flagged by the market sweep
Pulled back while its group leadsTape · 2026-11-13
3 lower closes in a leading group, 50d held, at 13.49
Mixed: stocks have lagged random stocks by 1.0% over three sessions, not consistently enough to call (433 cases over 59 nights). Against their own sector they have lagged by 0.9%.
GappedTape · 2026-11-06
-5.0%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Reported resultsFiling · 2026-11-05
2.02
No measurable effect: stocks behave like random ones over the next three sessions (2,340 cases over 54 nights).
GappedTape · 2026-11-05
+9.6%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-03
above 20d & 50d on 1.7x volume at 14.33
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
GappedTape · 2026-11-03
+7.7%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Closed above its 20- and 50-day on heavy volumeTape · 2026-10-29
above 20d & 50d on 1.9x volume at 12.62
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
Earnings comingEvent · 2026-10-27
reports 2026-10-28
No measurable effect: stocks behave like random ones over the next three sessions (2,970 cases over 40 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

What analysts expect
Strong buy3
Buy4
Hold5
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

No completed base to compare this one with yet.

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Cushman & Wakefield Ltd. (CWK) — The Tape